Sort by: Latest openings
frontiermeds.com
frontiermeds.com • Boston • Oncology Therapeutics • Drug Discovery • Startup • New • RA Capital Management · MPM BioImpact • Hiring now · 2 of 5
Frontier Medicines is boldly advancing science to defeat disease by pioneering innovations in precision-based medicines to target undruggable therapies
No named decision-maker yet.
Careers mailbox is known
Sep 23 AI Cheminformatics Engineer I crossed 90 days open Sep 18 Added to the stack Machine Learning Sep 16 Posted 2 roles Director/Sr. Director, Corporate Controller, Director, Clinical Supply Chain Sep 15 Posted a role, closed 1 Sr. Clinical Trial Manager
5 open $229k stated pay, 5 roles
Board re-checked 8 min ago · 6 events in 14 days
Follow
5 roles
···
elevate.bio
elevate.bio • Pittsburgh • Health Care • Cell & Gene Therapy • 201-500 employees • Founded 2017 • Startup • New • EcoR1 Capital · MPM BioImpact • Hiring now · 3 of 10
ElevateBio is powering the industry with an integrated approach to technologies and manufacturing.
No named decision-maker yet.
Careers mailbox is known
Sep 27 2 roles crossed 45 days open Sep 26 Posted 10 roles Associate I, QC Analytics (Contract, Multiple Positions), Engineer II, Facilities
10 open +1 this week $179k stated pay, 7 roles
Board re-checked 4 hours ago · 13 events in 14 days
Follow
10 roles
···
recodetx.com
recodetx.com • Menlo Park • Health Care • Vaccines • 51-200 employees • Startup • New • EcoR1 Capital · MPM BioImpact +1
ReCode is the first genetic medicines platform to enable highly targeted delivery to organs, tissues and cells beyond the liver. Our pipeline of rare disease therapeutics uses optimized mRNA and gene correction with redosing capability.
No named decision-maker yet.
Careers mailbox is known
Sep 26 Moved to Greenhouse
Board re-checked 14 min ago · 1 event in 14 days
Follow
···
umoja-biopharma.com
umoja-biopharma.com • Seattle, United States +1 offices • Oncology Therapeutics • Cell & Gene Therapy • Founded 2019 • Startup • New • Venture round $210M · 5 yr ago • MPM BioImpact • Likely open · 1 of 3
Umoja Biopharma pioneering immunotherapy by reprogramming T cells in vivo to target cancer cells and generate lasting remission.
Andrew Scharenberg · Executive Officer, Director · decision-maker · no contact
Irena Melnikova · Executive Officer · decision-maker · no contact
Luke Evnin · Director · no contact
John Hamer · Director · no contact
Careers mailbox is known
Sep 27 Executive Director, Corporate Securities Counsel crossed 45 days open Sep 25 Posted a role Senior Director, Clinical Regulatory Affairs Sep 18 Added to the stack Windows Sep 16 Posted a role Senior Manager, Clinical Regulatory Affairs
3 open $291k stated pay, 3 roles
Board re-checked 4 hours ago · 5 events in 14 days
Follow
3 roles
···